Development and validation of HIV SMRTcap for the characterization of HIV-1 reservoirs across tissues and subtypes
PLOS Pathogens · 13.01.2026 · 22 (1) · e1013171
DOI: 10.1371/journal.ppat.1013171 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 13.01.2026. Verfasst von Ghazal Sadri und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, Kentucky, United States of America. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Virus Integration, Proviruses. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIMH NIH HHS, NIDA NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Human Immunodeficiency Virus type 1 (HIV-1) is responsible for the global HIV/AIDS epidemic and the establishment of an integrated HIV-1 reservoir remains the primary obstacle to cure. Upon therapy interruption, reactivation of the persistent HIV-1 reservoir propagates viral rebound and mediates continued immunological decline. While furthering understanding of the HIV-1 reservoir is essential for HIV-1 cure, commonly used sequencing strategies are often limited by the reliance on short-read sequencing across separate assays to determine integration sites and proviral integrity – something that does not always adequately resolve complex human genomic repeats or low complexity regions. Simultaneous identification of proviral integration sites and proviral integrity at the single molecule level would enable HIV-1 reservoir characterization with minimal imputation or bioinformatic reconstruction. Here we present HIV Single Molecule Real Time Capture (HIV SMRTcap), a novel molecular and computational pipeline that directly and simultaneously identifies HIV-1 integration sites, defines proviral integrity, and characterizes clonal expansion of HIV-1 provirus-containing cells with single molecule resolution. In combination with long-read, single-molecule, real-time (SMRT) sequencing and custom analytic pipelines, HIV SMRTcap enables a highly comprehensive characterization of HIV-1 reservoirs. Moreover, we demonstrate here that HIV SMRTcap performs robustly across the major global subtypes (HIV-1 subtype A, B, C, D and A/D recombinant viruses), and can use both cell- and tissue-derived inputs, including samples from antiretroviral therapy (ART) treated individuals with undetectable viral loads. Our results demonstrate that HIV SMRTcap serves as a comprehensive, robust method for unbiased HIV-1 reservoir characterization. Used alone, or in combination with single-cell based methods, HIV SMRTcap will enable novel exploration of viral reservoirs across subtypes and in tissue-specific compartments, providing critical information needed to inform HIV-1 cure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, Kentucky, United States of America.
- Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
- Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, United States of America.
- Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, United States of America.
- Weill Cornell Medicine, Graduate Program in Immunology and Microbial Pathogenesis, Weill Cornell Graduate School of Medical Sciences, New York, New York, United States of America.
ORCID-Profile: Melissa L Smith
Förderung
- NIMH NIH HHS
- NIDA NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- NIAID NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Sadri, G., Nadakal, S. T., Lauer, W., Kos, J., Singh, P. K., Elliott, E., Kaiser, C. W., Ford, E. E., Richardson, N., Shields, K. M., Hudson, E., Linden, N. L., Danesh, A., Powell, J., Warburton, P., Soto, J., Emery, M., Deikus, G., Lee, G. Q., …, & Smith, M. L. (2026). Development and validation of HIV SMRTcap for the characterization of HIV-1 reservoirs across tissues and subtypes. PLOS Pathogens, 22(1), e1013171. https://doi.org/10.1371/journal.ppat.1013171
Vancouver
Sadri G, Nadakal ST, Lauer W, Kos J, Singh PK, Elliott E, et al. Development and validation of HIV SMRTcap for the characterization of HIV-1 reservoirs across tissues and subtypes. PLOS Pathogens. 2026;22(1):e1013171. doi:10.1371/journal.ppat.1013171
BibTeX
@article{Sadri2026,
author = {Sadri, Ghazal and Nadakal, Steven T and Lauer, William and Kos, Justin and Singh, Parmit K and Elliott, Erin and Kaiser, Catherine W and Ford, Easton E and Richardson, Nadia and Shields, Kaitlyn M and Hudson, Elizabeth and Linden, Noemi L and Danesh, Ali and Powell, James and Warburton, Peter and Soto, Juan and Emery, Matthew and Deikus, Gintaras and Lee, Guinevere Q and Lamers, Susanna L and Reynolds, Steven J and Galiwango, Ronald and Prodger, Jessica L and Tomusange, Stephen and Kityamuweesi, Taddeo and Han, Tina and Jones, R Brad and Tobian, Aaron A R and Engelman, Alan N and Sebra, Robert and Morgello, Susan and Redd, Andrew D and Sachs, David and Rouchka, Eric and Smith, Melissa L},
title = {Development and validation of HIV SMRTcap for the characterization of HIV-1 reservoirs across tissues and subtypes},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {1},
pages = {e1013171},
doi = {10.1371/journal.ppat.1013171}
}
EUVIMED